Shanghai Pharmaceuticals (02607): Liversartan tablets obtain US FDA approval number

Wisdom Financial News APP News, Shanghai Pharmaceuticals (02607) announced that recently, its subsidiary Changzhou Pharmaceutical Factory Co., Ltd. (hereinafter referred to as "Changzhou Pharmaceutical Factory") received a notification from the Food and Drug Administration of the United States (FDA) that its Abbreviated New Drug Application (ANDA) for Rivaroxaban tablets, a generic drug application in the United States, has been approved.